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1. Introduction 
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable respiratory 
disease with some significant extrapulmonary effects that may contribute to the severity in 
individual patients. Its pulmonary components are characterized by airflow limitation that is 
not fully reversible. COPD is a leading cause of morbidity and mortality worldwide. The 
economic and social burdens due to it are substantial and anticipated to increase in the coming 
decades due to continued exposure to COPD risk factors and the changing age profile of the 
world’s population. COPD mortality trends generally track several decades behind smoking 
trends. In US in 2000, more women than men died of COPD or its related complications. 
COPD comprise of a heterogeneous group of disorders conventionally including 
emphysema, chronic bronchitis, peripheral airways disease and pulmonary vascular 
disease. It is a disease state that has seen significant changes in defining and excluding 
criteria over past 50 years. Spirometry, the most frequently used tool to diagnose COPD and 
to assess response to treatment in these patients, can provide only functional assessment. In 
contrast to spirometry, radiological imaging allows for regional assessment of the various 
compartments involved i.e. airways, parenchyma and vasculature. High-resolution 
computed tomography (HRCT) is recommended for the non-invasive and sensitive 
assessment of morphological changes in emphysema and has been shown to correlate well 
with pathology. With the advent of new imaging techniques like multi-detector row CT 
(MDCT), contrast-enhanced CT methods, spirometric controlled MDCT, use of Xenon gas to 
assess regional ventilation of the lungs, magnetic resonance imaging (MRI) of the lung 
developing its own arsenal like hyperpolarized  He-3 MRI  – new avenues are being opened 
up which are now increasingly supplemented with advanced and dedicated softwares.  
2. Advantages of high resolution computed tomography 
At present the diagnostic criteria recommended by the Global Strategy for the Diagnosis, 
Management and Prevention of Chronic Obstructive Lung Disease (GOLD guidelines) do 
not consider CT findings during initial diagnostic assessment (Pauwels & Buist 2001) and 
principally rely on spirometry. However, enough scientific literature suggests that HRCT is 
an important and indispensable tool for evaluation of COPD. Some of the uses of HRCT are 
described below in next sections. 
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2.1 Identifying causes of airway obstruction other than COPD  
Chronic airflow obstruction may be caused by a wide variety of diseases like bronchiectasis, 
upper airway lesions, bronchiolar diseases, interstitial lung diseases etc that may often 
produce clinical symptoms inseparable those due to COPD. HRCT can clearly identify 
different causes of airflow obstruction. Kurashima et al (2005) showed in 516 consecutive 
patients whose postbronchodilator FEV1/FVC was less than 70%, HRCT was able to 
identify 12.7% of patients with pulmonary diseases other than COPD including sarcoidosis, 
diffuse panbronchiolitis and pneumoconiosis. The exact diagnosis of underlying pathology 
leading to air flow obstruction is essential in management and to predict response to 
treatment in these patients.   
2.2 Identification of emphysema before appearance of clinical symptoms  
HRCT can detect pulmonary emphysema even in asymptomatic smokers with normal lung 
functions. Recent GOLD guidelines have abolished stage 0 that included asymptomatic 
patients who were smokers and had normal lung functions; however, Sverzellati et al (2007) 
observed that 13/18 subjects with stage 0 had emphysema detected over HRCT scan. It reflects 
that HRCT is a sensitive tool to detect emphysema before it is manifesting clinically or with 
deranged pulmonary functions. Detection of early emphysema may be of enormous value to 
prevent its progression by smoking cessation and medical intervention (Morgan 1992).  
2.3 Identifying and quantifying emphysema in patients with COPD   
Emphysema, characterised by a parenchymal-predominant pathology in COPD and chronic 
bronchitis with an airway-predominant one are distinct phenotypes and might have evolved 
due to different responses to and pathogenesis related to smoking (Patel et al 2006). The 
emphysematous phenotype is conventionally associated with a more severe form of disease 
(Boschetto et al 2003, 2006). COPD patients with emphysema on HRCT have been observed 
to have higher BODE index (body mass index, airflow obstruction, dyspnoea, exercise 
performance) and a lower inspiratory capacity to total lung capacity ratio (IC/TLC) than 
those without emphysema. This suggests emphysematous patients have more extensive 
systemic involvements (Boschetto et al 2006). The ability to separate airway-predominant 
from parenchymal-predominant pathology in COPD may prove useful in applying specific 
therapies designed to prevent airway remodelling and parenchymal destruction (Grenier 
2005).  
HRCT often makes it possible to distinguish between different phenotypes of emphysema: 
smoking related phenotype, the centriacinar emphysema; and phenotype associated with 
α1-antitrypsin deficiency, panacinar emphysema. Moreover, HRCT can detect the 
coexistence of both panacinar and centriacinar emphysema in the same individual, as some 
patients with α1-antitrypsin deficiency may also be smokers (Copley et al 2002). 
2.4 Detection of co-existing bronchiectasis  
Presence of bronchiectasis in COPD patients on functional evaluation using spirometry is often 
not detected; this fact become appreciable when HRCT studies are done. One study observed 
that 29% of COPD patients who were having frequent exacerbations had bronchiectatic 
changes detected on HRCT (O’Brien et al 2000). Patel et al (2004) found that the extent of lower 
lobes bronchiectasis in these patients was related to colonization by the potential pathogens, 
increased inflammatory markers, and a longer time to symptom recovery after exacerbation. 
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The likely pathogenesis for typical structural abnormalities seen on HRCT include damaged 
muco-ciliary transport, localized or diffuse peripheral obliteration of the bronchial tree and 
lung tissue scarring – all these may be acting in concert in COPD.  
2.5 Evaluation of large airways   
Airway predominant pathology in COPD is significant and it is diagnosed conventionally 
based on clinical symptomatology of chronic or recurrent excess of mucus secretion in the 
bronchial tree (chronic was defined as occurring on most days of three months of a year, for 
at least two successive years), in whom other causes of chronic cough have been excluded 
(American thoracic society 1995). With the development of multidetector-row computed 
tomography (MDCT) understanding of the larger airway diseases has been improved 
dramatically. Volumetric thin-section CT scans are able to detect small pits or diverticulae 
along the inner surfaces of the large bronchi (Zompatori et al 2006). These pits are supposed 
to correspond to dilated bronchial gland ducts opening into the large airway lumen (Grenier 
et al 2004; Zompatori et al 2006). 
2.6 Assessment of regional distribution of emphysema 
HRCT scan can also provide details regarding regional distribution of emphysema. The role 
of distribution of emphysema on HRCT as a predictor of mortality is a hot topic. One study 
reported a greater proportion of emphysema in the lower lung versus the upper lung to be 
predictive of mortality; the authors speculated that lower-lobe emphysema may be either a 
marker of increased disease severity or, alternatively, a phenotypic or pathobiologic variant 
(Martinez et al 2006). Other studies explored the influence of the distribution pattern of 
emphysema on different lung function parameters. A higher percentage of emphysema in 
the core was associated with a more reduction in diffusion capacity (Aziz et al 2005). The 
contribution of emphysema at core to pulmonary dysfunction (with FEV1/ FVC %) may be 
larger than at periphery (Nakano et al 1999). 
2.7 Essential for surgical interventions in COPD 
Two surgical therapies, bullectomy and lung volume reduction surgery (LVRS), are sometimes 
recommended in COPD patients. A chest radiograph may suggest the presence of bullae, but 
accurate existence and extent of such lesions can only be assessed with chest CT scans 
(Martinez & Chang 2005). Similarly, the presence, extent, and distribution of emphysema can 
precisely be determined with a chest CT scan. The work over lung volume reduction surgery 
(LVRS) suggests more benefits in patients with upper lobe emphysema (Cooper et al 1995).  
A chest CT scan is an important tool to determine patients who should not undergo LVRS 
(Group NETTR 2001). In NETT, LVRS was associated with a high risk of death (16% with 
LVRS compared with 0% in subjects treated medically) at 30 days in two types of subjects 
with emphysema: (1) those with FEV1 of less than or equal to 20% of predicted and non–
upper lobe–predominant disease, and (2) subjects with FEV1 of less than or equal to 20% of 
predicted and a diffusing capacity less than or equal to 20% of predicted. 
3. High resolution computed tomography: evolution with the time 
During the last couple of decades, HRCT has been widely used to evaluate emphysematous 
and chronic bronchitis components of COPD. The initial work by Edinburg group was to 
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use computed tomography to diagnose emphysema in living patients (Gould et al 1988). 
Since then, HRCT has been widely established to detect and quantify COPD and its 
subtypes. Several workers have studied the correlation of semi-quantitative scoring of 
COPD by HRCT, pathology, clinical features and pulmonary function tests (Sanders et al 
1988; Gupta et al 2008, 2009). HRCT indices of emphysema reflect lung anatomy and 
represent the best way to assess emphysema severity in life (Newell et al 2004). The 
introduction of multidetector-row CT (MDCT) scanners has provided powerful tools to 
evaluate changes in both small and large airways. In addition, dynamic imaging via MDCT 
allows the assessment of perfusion and ventilation in the lung parenchyma. Therefore, CT is 
able to precisely define the pathological process by providing accurate anatomic 
informations as well as functional data from the area of interest. 
The parameters that have been extensively used by different workers to detect and  
differentiate various diseases grouped under COPD, and to quantify these diseases are 
described in following sections. 
4. Measurements of lung density 
The digital data provided by HRCT can be analyzed to detect the presence and severity of 
emphysema by several means. The measurement of lung density for quantifying 
emphysema may be done by visual estimation or automated techniques, both of which 
have their proponents (Desai et al 2006). These methods demonstrated good correlation with 
pathological assessment of emphysema severity (Muller et al 1988; Gevenois et al 1996). The 
extent of the lung density representing the disease can be visually graded according to a 
categorical scale. A potential drawback of visual estimation is inter-observer variation, 
although observer disagreement in scoring the extent of emphysema has been an 
insignificant factor in many of previous studies (Desai et al 2006). The potential 
interobserver variation is balanced by the speed and the simplicity of the technique.  
The extent of emphysema can be determined by using a threshold technique for image 
segmentation. This is accompanied by setting of lower threshold for normal lung 
attenuation. The total area of volume of lung is calculated first using the lower threshold 
value and amount of emphysematous lung is determined by calculating the percentage of 
lung that is less than threshold value (Muller et al 1988). This technique is called as 
“density mask method”. Routinely, –910 HU is taken as threshold value. In a study, 
authors compared CT lung densitometry in 20 COPD patients and in control subjects 
(Lamers et at al 1994). They found that percentage of pixels with attenuation less than –
910 HU correlated well with visual emphysema score. In another study, HRCT scans were 
obtained with 1 cm intervals in 38 subjects (Gevenois et al 1996). The percentage areas 
occupied by attenuation values inferior to thresholds ranging from –900 HU to –970 HU 
were calculated. Emphysema was microscopically quantified in resected lung specimen. 
The strongest correlation was found for –950 HU and pulmonary function tests also 
correlated with emphysema measured by density mask method. However, other workers 
tried to correlate relative areas occupied by attenuation values lower than eight 
thresholds ranging from –900 to –970 HU with macroscopic emphysema and observed 
that a standard can not be recommended for the measurement of emphysema. Using 
precise morphometric evaluation of resected lung tissue, Bankier et al (1999) showed that 
observers, regardless of their experience, tend to overestimate the extent of emphysema 
on CT, whereas CT densitometry correlates better with the morphometric reference. The 
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density mask has been used to identify subgroups of patients who may show benefit from 
lung volume reduction surgery (Fishman et al 2003). The percentage of emphysema 
quantified by density mask is also predictive of survival in α1-antitrypsin–induced 
emphysema (Dawkins et al 2003). 
Another objective way to measure emphysema on HRCT is assessment of mean lung 
density (Nowell 2002). CT density is expressed as a linear scale in HU (water = 0, air = –
1000). In this range, lung density is a direct measure of physical density and is determined 
by the relative mix of air, blood and interstitial fluid in tissue. Emphysema will lead to 
decrease in mean lung density on CT. Several studies have assessed CT lung density in 
normal subjects. However, the range of normality remains to be standardized. In a study, 
authors assessed the progression of pulmonary emphysema in 23 patients by means of lung 
density (Zagiers et al 1996). Patients were scanned twice with a 1 year interval. Mean lung 
densities decreased within this duration and proved to be more sensitive than FEV1 and 
carbon monoxide diffusion. 
The image histogram curve of CT lung density values can be obtained using softwares and 
measures of skewness can be looked at as another mean of detecting and assessing the 
presence of emphysema. Tail of high density value is produced by large vessels and airways 
and in emphysema, there is an increase in the numbers of low density pixels and the whole 
curve is shifted to the left (MacNee et al 1991). In a study, three groups of individuals, 20 
with emphysema, 20 with chronic bronchitis and healthy individuals underwent CT and 
cut-off point in the histogram that defines the lowest 10th percentile of the histogram was 
derived (Lamers et al 1994). They observed that it is possible to classify lung disease using 
this parameter. 
The softwares available in addtion with MDCT scanners make it possible to recognize and 
quantify emphysema faster than human evaluation; and it is now possible to apply techniques 
measuring lung density to volumetric data. The resolution achieved in thoracic HRCT allows 
the application of high-precision 3D image analytic tools to CT data (Kuhnigk et al 2005). The 
analyses allow a convenient regional assessment of CT parameters including total volume, 
mean density, pixel index, and emphysema type (Kuhnigk et al 2005).  
A density-masking approach alone is not sufficient to accurately distinguish between 
normal and diseased lung, especially in the case of early or mixed pathologic processes 
(Uppaluri et al 1997, 1999; Hoffman et al 2006). Further, CT densitometry is known to be 
influenced by several factors (eg, age, weight, beam hardening from adjacent ribs etc.) and 
calibration must be performed in order to obtain reliable densitometry. Neither visual nor 
pure densitometric approaches to CT quantification of emphysema are, therefore, perfect. 
In addition to assessment of percentage of voxels below a certain threshold, more 
sophisticated analytic softwares may analyse the CT scan data, contiguous 
emphysematous lesions can be clustered to obtain the volumes for small-sized, medium-
sized, and large-sized emphysematous areas (cluster distribution) (Blechschmidt et al 
2001; Zaporozhan et al 2005). A serial assessment of cluster distribution is useful in 
revealing the pattern of progression of emphysema. Uppaluri et al (1997, 1999) examined 
multiple features of the CT images and X-ray attenuation values to describe the lung and 
developed the Adaptive Multiple-Feature Method (AMFM), which can assess up to 22 
independent textural features from HRCT scans to classify a tissue pattern. This is found 
to be useful to distinguish smokers from non-smokers in the absence of other disease 
(Hoffman et al 2006).  
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5. Mosaic attenuation pattern and air trapping 
Abnormalities on HRCT that reflect small airways disease can be broadly categorized into 
indirect and direct signs: widespread scarring and obliteration of the bronchioles results in 
the indirect sign of patchy density differences of the lung parenchyma, representing areas of 
under-ventilated and under-perfused lung (mosaic attenuation pattern). The considerable 
thickening of the small airways walls by inflammatory infiltrate and/or luminal and 
surrounding exudate render the affected small airways directly visible (Hansell 2001). Air 
trapping or hyperinflation is a common manifestation of COPD (Stern & Frank 1994). 
Persistent aeration caused by collateral pathways, or hyperaeration from trapped air, 
produces the mosaic attenuation pattern which is characterized by nonhomogenous lung 
density, i.e. areas that remain relatively lucent interspersed with areas of normal higher lung 
density. The air trapping and mosaic attenuation pattern is more pronounced, on scans 
obtained at end-exhalation instead of the more conventional end-inspiration technique 
(Arakawa & Webb 1998). In a recent study, it was found that mosaic attenuation pattern in 
addition to other HRCT features is helpful in distinguishing different entities grouped 
under COPD (Copley et al 2002). 
 
 
Fig. 1. HRCT scans showing non-homogenous lung density – a cardinal feature of mosaic 
attenuation pattern (A-F) observed on HRCT scan obtained from different COPD patients.  
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In our studies (Gupta et al 2008, 2009) including 40 COPD patients who were diagnosed 
based on GOLD criteria and who were evaluted for HRCT characteristics, 16/40 patients 
had classic mosaic attenuation pattern; the HRCT scans were undertaken during full 
inspiration. Some of these are shown in figure 1 (A to F).  
6. Directly visible small airways  
Several pathological studies have shown that the major site of airway obstruction in COPD  
is in airways with internal diameter lesser than 2 mm. The 2 mm airways are located 
between the fourth and the 14th generation of the tracheobronchial tree. These airways are 
not visible on HRCT scan in normal subjects. However, considerable thickening of the 
bronchiolar walls by inflammatory infiltrate  and/or luminal and surrounding exudates 
render them directly visible (Hansell 2001). These diseased airways are visible on HRCT as 
dilated, air-filled, branching, tubular or ring-like structures in the lung periphery by wall 
thickening and dilation. When the airways are obliterated by submucosal or peribronchial 
fibrosis, nodular, linear, or branching peripheral opacities may be seen (Teel et al 1996). In 
our study, 36 out of 40 COPD patients showed directly visible small airways (figure 2). 
 
 
Fig. 2. HRCT axial scans showing directly visible small airways as (A-C) air filled ring like 
structures and (D) air filled branching tubular structures. 
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7. Measurements of airway wall thickness  
It has been observed that the size of the large and intermediate airways reflect airway 
dimensions in the smaller airways (Nakano et al 2005). Due to the interobserver 
disagreement in the visual interpretation of bronchial wall thickness on CT scans (Muller 
and Coxson 2002), there has been considerable interest in the development of objective 
measurements of airway wall dimensions. The most frequently reported method for 
measuring the airway lumen and wall areas relies on the “full-width-at-half-maximum” (or 
“half-max”) technique, in which the inner and outer airway wall boundaries are defined as 
the point corresponding to the half maximal intensity of the airway wall voxels (Nakano et 
al 2000; de Jong et al 2005). Using the half-max method, Nakano et al (2000) showed that an  
increased thickness of the apical right upper lobe bronchus over HRCT  correlated with the 
severity of airflow obstruction in COPD patients. However, the measurements of airway 
lumen and wall area depends on the lung volume and angle between the airway central axis 
and the plane of section (Grenier et al 2004).  
In 42 COPD patients, bronchi with external diameter of greater than 2 mm and maximum to 
minimum diameter ratio less than 1.5 were selected (Orlandi et al 2005). Thickness to 
diameter ratio (TDR) and the percentage wall area (PWA) of these bronchi were computed. 
For each patient, mean TDR and mean PWA were calculated. The combination of PWA, 
TDR and PWA normalized to body weight correlated significantly (P < 0.05) with 
FEV1/SVC ratio and DLco in patients with chronic bronchitis but not in patients without 
chronic bronchitis. 
In another study, thickness to diameter ratio (TDR), and percentage of wall area (WA%) 
were calculated on HRCT in 4 groups of patients : group O - healthy non smokers, group I - 
healthy current smokers, group II - patients with moderate COPD and group III - those with 
severe COPD as per GOLD classification (Deveci et al 2004). Both groups II and III had 
higher T/D ratio and WA% than group I and group I had higher values than group O. 
Airway wall thickening was found to be inversely correlated with FEV1 and positively 
related to the quantum of smoking. 
8. Low attenuation areas of emphysema  
HRCT is a reliable tool for demonstrating even subtle changes in secondary pulmonary 
lobules. Low attenuation areas of emphysema are distinctly visible on HRCT scan. These 
focal areas of decreased attenuation present differently in different types of emphysema 
(Nowell 2002).  
Centriacinar emphysema is the commonest type of pulmonary emphysema and is 
characterized by an enlargement of the centriacinar airspace, with the effect mainly 
occurring in proximal respiratory bronchioles, leaving normal distal alveolar ducts and sacs. 
In centriacinar emphysema, focal areas of decreased attenuation have no discernable wall 
and usually have a focal arteriole at or near the centre of lesion (Figure 3 A-F). Centriacinar 
abnormalities always have a distance of about 2.5 mm from the perilobular structure, 
including interlobular septum, pleura and large pulmonary vessels. Cigarette smoking and 
dust inhalation are the most important risk factors for the development of centriacinar 
emphysema. The disease is usually distributed to the upper lobe or the superior segment of 
the lower lobe. The inner zone is more severely affected than the outer zone, probably due 
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Fig. 3. HRCT scans in patients with centriacinar emphysema showing multiple, round lucent 
regions of various sizes surrounded by normal parenchyma (A-F). 
to zonal differences in respiratory kinetics and lymph flow. HRCT in early centriacinar 
emphysema shows evenly distributed centrilobular tiny areas of low attenuation with ill-
defined borders; with enlargement of the dilated airspace, the surrounding lung 
parenchyma is compressed and a clear border may be observed between the 
emphysematous area and normal lung. 
www.intechopen.com
  
Bronchitis 
 
158 
Panacinar emphysema is characterized by a uniform dilatation of the air space from the 
respiratory bronchioles to the alveoli, leading to evenly distributed emphysematous changes 
within secondary lobules. Panacinar emphysema is characterized by large areas of 
decreased lung density or decreased attenuation on CT with poorly defined margins; the 
caliber of the vessels in the involved area is decreased due to overinflation of the air space 
[Figure 4 (A-D)]. Alpha 1-antitrypsin deficiency is thought to be a major cause of panacinar 
emphysema. Other rare etiologies, including Swyer-James syndrome and ritalin abuse, have 
been reported. The characteristics that distinguish panacinar emphysema from centriacinar 
emphysema are as follows: the disease is dominant in the lower lung field, the degree of 
lung inflation is greater than that in centriacinar emphysema; there is a tendency for the 
airway to be narrowed; and bullous formation is less frequently observed compared to 
centriacinar emphysema.  
 
 
 
Fig. 4. (A-B): Panacinar emphysema: HRCT scans showing diffuse low attenuation lung 
parenchyma – typical of panacinar emphysema 
Distal acinar emphysema is characterized by focal areas of subpleural emphysema. Distal 
acinar or paraseptal emphysema is characterized by an enlarged airspace at the periphery of 
acini. The lesion is usually limited in extent, occurs most commonly along the dorsal surface 
of the upper lung. The patients are usually asymptomatic, but distal acinar emphysema is 
considered to be a cause of pneumothorax in young adults. 
The subtypes of emphysema can usually be determined in mild or moderate cases, but 
classification into anatomic subtypes becomes more difficult by HRCT and pathological 
examinations as emphysema becomes more severe, with even highly trained and 
experienced pathologists sometimes disagreeing on the classification. Centriacinar and 
panacinar emphysema may coexist in the same patient; for example, with centriacinar 
emphysema in the upper lobe and panacinar emphysema in the lower lobe.   
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Fig. 4. (C-D): Some more HRCT scans showing panacinar emphysema  
 
 
Fig. 5. (A-D): HRCT scans showing small subpleural areas of hyperlucency – characteristic 
of paraseptal emphysema. 
Studies have been done to assess the accuracy of CT in diagnosis of emphysema by visual 
scoring of low attenuation areas. In a study, CT thorax was performed on 32 patients 
scheduled for elective thoracotomies for suspected lung tumours (Bergin et al 1986). Each 
slice was assessed and graded depending upon the percentage area showing 
emphysematous areas. Similarly, emphysema was graded on the resected lung specimens. It 
was found that compared to pulmonary function tests, CT was a better predictor of 
assessing the presence and severity of emphysema. 
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A retrospective study used HRCT scans for scoring the severity of emphysema (Klein et al 
1992). Each of the six lung sections was evaluated and extent of emphysema multiplied by 
the severity was summed for the six sections. Concomitant chest radiographs and 
pulmonary function tests were reviewed. The severity of emphysema on HRCT correlated 
inversely with single breath carbon monoxide diffusion capacity. HRCT allowed detection 
of emphysema in symptomatic patients when chest radiographs and pulmonary function 
tests were non-diagnostic. 
 
 
Fig. 6. (A-D) : HRCT scans of different COPD patients showing vascular attenuation 
characterized by thinning of pulmonary vessels at the peripheral lung field along with 
reduction in their number. 
9. Vascular attenuation and vascular distortion  
On HRCT of emphysema patients, low attenuation areas are frequently accompanied with 
vascular attenuation and distortion (Norwell 2002). Vascular attenuation is defined as 
thinning of pulmonary vessels and reduction in their number [figure 6 (A-D)]. Vascular 
distortion is increased branching angles, excessive straightening or bowing of vessels. 
[figure 7 (A-D)]. 
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Fig. 7. (A-D): HRCT axial scans from COPD patients showing vascular distortion characterized 
by increased branching angles and excessive straightening of pulmonary vessels. 
In a study, two radiologists and one chest physician assessed for destructive changes of 
emphysema manifested by low attenuation areas and disruption of vascular pattern (Kuwano 
et al 1990). Each slice was individually assessed using a modification of the picture-grading 
system of Thurlback (1994). CT scores correlated significantly with the pathological scores and 
it was concluded that HRCT can help to identify the presence and grading of mild 
emphysema. Other studies have found that vascular disruption in addition to areas of low 
attenuation is helpful in assessing and grading emphysema  (Bergin et al 1986). 
10. Saber-sheath trachea and tracheal index  
In cross-section, the resting trachea is roughly horse-shoe shaped, with the open end of the 
cartilage rings closed by a compliant posterior sheath. In COPD patients, the coronal 
diameter is reduced and the saggital diameter correspondingly increased, a condition called 
saber-sheath trachea [Figure 8 (A-D)] . Tracheal index is a ratio of the coronal to the saggital 
length,  measured 1 cm above the aortic arch. 
www.intechopen.com
  
Bronchitis 
 
162 
In a study, it was found that patients with COPD had a reduced tracheal index. Saber-sheath 
trachea (tracheal index < 2/3) was observed to be a specific radiographic diagnostic 
parameter for the diagnosis of COPD (specificity, 92.9%), although sensitivity (39.1%) was 
low (Tsao et al 1994). 
 
 
Fig. 8. (A-D): Saber sheath trachea over CT scans in COPD patients 
In another study (Trigaux et al 1994), 20 patients with saber-sheath trachea were compared 
with 20 controls without saber-sheath trachea by measuring standard HRCT indices of 
COPD and functional tests including FEV1, DLco and FRC. Tracheal index was significantly 
correlated with the FRC values and it was concluded that saber-sheath trachea is basically a 
sign of hyperinflation in COPD pateints. Similarly, in a different study (Arakawa 1998), 
reduced tracheal index and other signs of hyperinflation of thoracic cage on CT were found 
to correlate significantly with pulmonary functions of chronic airway obstruction. 
11. Sterno-aortic distance and mediastinal anterior junctional line  
In retrosternal region, right and left lung with their corresponding pleural layers 
approach each other so closely that the area of contrast form a linear density. When 
present, the line is 1 to 2 mm wide and formed by two pleural layers on each side of a 
narrow zone of mediastinal connective tissue. This line is called anterior junctional line 
(AJL) [figure 9 (A-D)].  
www.intechopen.com
 High Resolution Computed Tomography and Chronic Obstructive Pulmonary Disease 
 
163 
 
Fig. 9. (A-D): HRCT scans from COPD showing increased sterno-aortic distance and the 
anterior junctional line. 
In a study, AJL and sterno-aortic distance (distance between sternum and ascending aorta) 
were measured in CT sections at carinal level in 22 patients with emphysema and 22 control 
subjects (Hagen & Kolebenstvedt 1993). The AJL could be measured in all emphysema 
patients. In the control group the line was non-existent in 11 of the 22 patients. The AJL was 3 
cm or more in 10 of the emphysema patients, but in none of the controls. The sterno-aortic 
distance was 4 cm or more in 16 of the emphysema patients, but in none among control group. 
In another study, significant correlation was found between FEV1 / FVC and sterno-aortic 
distance (measured at tracheal carina on CT) in 74 patients who underwent thoracic surgery 
for lung cancer (Arakawa et al 1998). 
12. Thoracic cage ratio and barrel chest  
Arakawa et al (1998) measured thoracic cage ratios (anteroposterior/ transverse diameters) 
at carina and 5 cm below carina on CT in 74 patients. Other measurements of hyperinflation 
were also calculated and it was found that increased thoracic cage ratio correlated most 
significantly with a pulmonary functions of chronic airway obstruction. 
In another study, normal thoracic cage ratio was 0.70 to 0.75 in adults. The thoracic cage 
ratio was found high in COPD patients and may reach upto > 0.9 which was called as barrel 
chest (Pierce et al 1958). Figure 10 (A-B) shows HRCT scans with barrel chest feature found 
in our studies (Gupta et al 2008, 2009).  
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Fig. 10. (A-B): A marked increase in thoracic cage ratio above 0.9 described as barrel  
chest 
13. Thoracic cross-sectional area (TCSA) index  
The assessment of thoracic cross-sectional area (TCSA) is an important measure of 
thoracic cage hyperinflation commonly seen in advance COPD with air trapping and 
increased total lung capacity. TCSA is the area surrounded by the rib cage measured on 
CT scan made 1 cm below the top of the aortic arch. In a study (Kasai et al 2003) TCSA 
and pulmonary functions and dyspnea grade were measured in 24 COPD patients. In the 
group with grade IV dyspnea, the TCSA/ht2 ratios were significantly greater than those in 
the groups with grade II and III dyspnea, combined. Analysis of data showed a good 
correlation between TCSA and total lung capacity, as well as functional residual capacity 
and residual volume.  
14. HRCT characteristics observed in our studies 
Our studies included 40 male patients with COPD. Their mean age was 58.55 years 
(range: 50-69 years). Total duration of illness due to COPD was in range from 2 to 25 years 
with a mean of 12.63 years. All subjects were significant smoker with mean smoking 
history of 33.25 pack years (range 20-74 pack years). They were evaluated for HRCT 
features including vascular attenuation and distortion, mosaic attenuation pattern, 
directly visible small airways, low attenuation areas of emphysema and measures of 
hyperinflation of lungs: tracheal index, sterno-aortic distance, thoracic cage ratio and 
thoracic cross-sectional area. Individual COPD patients having characteristics HRCT 
findings were as shown in table-1. 
In our studies, tracheal index was observed to have significant inverse correlations with 
duration of illness, smoking pack years, and dyspnea scale; and had direct correlations with 
FEV1, PEFR, FEV1/FVC ratio, and FEV1/SVC ratio. Thoracic cage ratio at carina as well as 
thoracic cage ratio at 5 cm below carina had direct correlations with duration of illness, 
smoking pack years and dyspnea scale; and had inverse correlations with FEV1, FEV1/FVC 
ratio and FEV1/SVC ratio. Sterno-aortic distance and thoracic cross sectional area had 
correlations with duration of illness, smoking pack years and dyspnea scale; and they had 
inverse correlations with FEV1, FEV1/FVC ratio, and FEV1/SVC ratio.   
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HRCT features 
Number of patients 
out of 40 
Percentage of study 
subjects 
Saber sheath trachea with tracheal index  
less than 0.67 
14 35 
Thoracic cage ratio over 0.75 at the level of 
carina 
5 12.5 
Thoracic cage ratio over 0.75 at the level 
5 cm below carina 
11 27.5 
Sterno-aortic distance  more than 4 cm 5 12.5 
Thoracic cross-sectional area/ht2 more than
80.00 cm2/m2 
28 70 
Vascular attenuation 25 62.5 
Vascular distortion 8 20 
Mosaic attenuation pattern 16 40 
Directly visible small airways 36 90 
Centriacinar emphysema 16 40 
Panacinar emphysema 11 27.5 
Paraseptal emphysema 13 32.5 
Any type of emphysema 25 62.5 
Table 1. HRCT features noted in individual COPD patients 
Vascular attenuation had significant correlations with duration of illness, dyspnoea scale, 
smoking pack years, FEV1, FEV1/FVC ratio, and FEV1/SVC ratio. Vascular distortion had no 
significant correlation with any of the observed parameter. The mosaic attenuation pattern 
correlated significantly with duration of illness, dyspnea scale, smoking pack years, FEV1, 
FEV1/FVC ratio, and FEV1/SVC ratio. Correlation of presence of directly visible small 
airways was significant only with dyspnea scale. Centriacinar emphysema had significant 
correlations with PEFR, FEV1, FVC, FEV1/FVC ratio and FEV1/SVC ratio. Correlations of 
presence of any type of emphysema with age, duration, dyspnea scale, pack-years, PEFR, 
FEV1, FVC, FEV1/FVC ratio and FEV1/SVC ratio were statistically significant.  
15. Recent advances  
COPD is a heterogeneous group of disorders and needs to be evaluated by a combination of 
morphological and functional assessment. Recently, newer HRCT techniques as well as MRI 
have provided new insights to characterisation of various pulmonary components of COPD in 
term of morphology as well as functionality. Three-dimensional HRCT has been described as 
the technique of choice for morphological imaging. Inspiratory and expiratory 3D-HRCT with 
volumetric and texture analysis allows for deeper insights to regional hyperinflation and 
expiratory obstruction. Three-dimensional HRCT has also been described as the “gold 
standard” for non-invasive quantitative evaluation of airway dimensions. Newer generations 
of MRI allow for better visual assessment of the lung morphology as well as comprehensive 
functional imaging. The major advantage of MRI is the assessment of regional lung function 
including perfusion, respiratory dynamics and ventilation. The comprehensive diagnostic 
possibilities of CT complemented by MRI will allow for a more sensitive detection, 
phenotype-driven characterization and dedicated therapy monitoring of COPD. 
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16. Conclusion 
While all this description appears voluminous, many things have not been discussed in 
detail due to want of space. The imaging techniques we are applying in day to day practice 
at present have opened new avenues for morphological and functional characterisation of 
various diseases incorporated under the heterogeneous group of COPD and helped in 
phenotyping as well as assessment of the progression of COPD. And, this is just beginning! 
In future we are definitely going to get more powerful equipments, supplemented with 
dedicated and advanced softwares that will provide deeper insight into the various diseases 
grouped under the umbrella of COPD. 
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